<!doctype html><html lang=en-us dir=ltr><head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta name=description content="In today’s decision in Generics (UK) v. Competition and Markets Authority [C-307/18, here], the Court of Justice of the European Union (CJEU) ruled that pay-for-delay agreements may violate Articles 101 and 102 of the Treaty on the Functioning of the European Union (TFEU). Under a pay-for-delay agreement, the holder of a pharmaceutical patent pays generics to stay off the market or delay their entry on the market. The decision is significant because it is the first time the CJEU addresses this issue."><title>CJEU rules that pay-for-delay agreements likely violate competition law where reverse payments occur without justifiable explanation</title><link rel=canonical href=https://Nexus-Security.github.io/posts/2016-09-09-cjeu-rules-that-pay-for-delay/><link rel=stylesheet href=/scss/style.min.450926226e724574a6b936335ea06111f8aeb253d932c86cb2cc807341cd2889.css><meta property="og:title" content="CJEU rules that pay-for-delay agreements likely violate competition law where reverse payments occur without justifiable explanation"><meta property="og:description" content="In today’s decision in Generics (UK) v. Competition and Markets Authority [C-307/18, here], the Court of Justice of the European Union (CJEU) ruled that pay-for-delay agreements may violate Articles 101 and 102 of the Treaty on the Functioning of the European Union (TFEU). Under a pay-for-delay agreement, the holder of a pharmaceutical patent pays generics to stay off the market or delay their entry on the market. The decision is significant because it is the first time the CJEU addresses this issue."><meta property="og:url" content="https://Nexus-Security.github.io/posts/2016-09-09-cjeu-rules-that-pay-for-delay/"><meta property="og:site_name" content="ZYChimne"><meta property="og:type" content="article"><meta property="article:section" content="Posts"><meta property="article:published_time" content="2020-01-30T23:35:00+01:00"><meta property="article:modified_time" content="2020-01-30T23:35:00+01:00"><meta name=twitter:title content="CJEU rules that pay-for-delay agreements likely violate competition law where reverse payments occur without justifiable explanation"><meta name=twitter:description content="In today’s decision in Generics (UK) v. Competition and Markets Authority [C-307/18, here], the Court of Justice of the European Union (CJEU) ruled that pay-for-delay agreements may violate Articles 101 and 102 of the Treaty on the Functioning of the European Union (TFEU). Under a pay-for-delay agreement, the holder of a pharmaceutical patent pays generics to stay off the market or delay their entry on the market. The decision is significant because it is the first time the CJEU addresses this issue."></head><body class=article-page><script>(function(){const e="StackColorScheme";localStorage.getItem(e)||localStorage.setItem(e,"auto")})()</script><script>(function(){const t="StackColorScheme",e=localStorage.getItem(t),n=window.matchMedia("(prefers-color-scheme: dark)").matches===!0;e=="dark"||e==="auto"&&n?document.documentElement.dataset.scheme="dark":document.documentElement.dataset.scheme="light"})()</script><div class="container main-container flex on-phone--column extended"><aside class="sidebar left-sidebar sticky"><button class="hamburger hamburger--spin" type=button id=toggle-menu aria-label="Toggle Menu">
<span class=hamburger-box><span class=hamburger-inner></span></span></button><header><figure class=site-avatar><a href=/><img src=/img/avatar_hue825486955cd7c56d95e38b4bd2a8e3c_229979_300x0_resize_box_3.png width=300 height=300 class=site-logo loading=lazy alt=Avatar></a></figure><div class=site-meta><h1 class=site-name><a href=/>ZYChimne</a></h1><h2 class=site-description>Computer Science, Wuhan University</h2></div></header><ol class=social-menu><li><a href=https://github.com/Nexus-Security target=_blank title=GitHub><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-brand-github" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z" fill="none"/><path d="M9 19c-4.3 1.4-4.3-2.5-6-3m12 5v-3.5c0-1 .1-1.4-.5-2 2.8-.3 5.5-1.4 5.5-6a4.6 4.6.0 00-1.3-3.2 4.2 4.2.0 00-.1-3.2s-1.1-.3-3.5 1.3a12.3 12.3.0 00-6.2.0C6.5 2.8 5.4 3.1 5.4 3.1a4.2 4.2.0 00-.1 3.2A4.6 4.6.0 004 9.5c0 4.6 2.7 5.7 5.5 6-.6.6-.6 1.2-.5 2V21"/></svg></a></li><li><a href=mailto:0x000216@gmail.com target=_blank title=Email><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-brand-gmail" width="44" height="44" viewBox="0 0 24 24" stroke-width="1.5" stroke="#2c3e50" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z" fill="none"/><path d="M16 20h3a1 1 0 001-1V5a1 1 0 00-1-1h-3v16z"/><path d="M5 20h3V4H5A1 1 0 004 5v14a1 1 0 001 1z"/><path d="M16 4l-4 4-4-4"/><path d="M4 6.5l8 7.5 8-7.5"/></svg></a></li><li><a href=https://www.buymeacoffee.com/0x000216 target=_blank title=Coffee><svg width="884" height="1279" viewBox="0 0 884 1279" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg"><defs><path d="M0 0H884V1279H0V0z" id="path_1"/><clipPath id="mask_1"><use xlink:href="#path_1"/></clipPath></defs><g id="buymeacoffee"><path d="M0 0H884V1279H0V0z" id="Background" fill="none" fill-rule="evenodd" stroke="none"/><g clip-path="url(#mask_1)"><path d="M791.109 297.518 790.231 297.002 788.201 296.383C789.018 297.072 790.04 297.472 791.109 297.518z" id="Shape" fill="#0d0c22" stroke="none"/><path d="M803.916 388.891l-1 1 1-1z" id="Shape" fill="#0d0c22" stroke="none"/><path d="M792.113 297.647C791.776 297.581 791.447 297.462 791.127 297.29 791.108 297.622 791.108 297.958 791.127 298.29 791.488 298.216 791.83 297.995 792.113 297.647z" id="Shape" fill="#0d0c22" stroke="none"/><path d="M791.113 298.447h1v-1l-1 1z" id="Shape" fill="#0d0c22" stroke="none"/><path d="M803.111 388.726 804.591 387.883 805.142 387.573 805.641 387.04C804.702 387.444 803.846 388.016 803.111 388.726z" id="Shape" fill="#0d0c22" stroke="none"/><path d="M793.669 299.515 792.223 298.138 791.243 297.605C791.77 298.535 792.641 299.221 793.669 299.515z" id="Shape" fill="#0d0c22" stroke="none"/><path d="M430.019 1186.18C428.864 1186.68 427.852 1187.46 427.076 1188.45L427.988 1187.87C428.608 1187.3 429.485 1186.63 430.019 1186.18z" id="Shape" fill="#0d0c22" stroke="none"/><path d="M641.681 1144.63C641.681 1143.33 640.424 1143.57 640.729 1148.21 640.729 1147.84 641.035 1147.46 641.171 1147.1 641.341 1146.27 641.477 1145.46 641.681 1144.63z" id="Shape" fill="#0d0c22" stroke="none"/><path d="M619.284 1186.18C618.129 1186.68 617.118 1187.46 616.342 1188.45L617.254 1187.87C617.873 1187.3 618.751 1186.63 619.284 1186.18z" id="Shape" fill="#0d0c22" stroke="none"/><path d="M281.304 1196.06C280.427 1195.3 279.354 1194.8 278.207 1194.61 279.136 1195.06 280.065 1195.51 280.684 1195.85L281.304 1196.06z" id="Shape" fill="#0d0c22" stroke="none"/><path d="M247.841 1164.01C247.704 1162.66 247.288 1161.35 246.619 1160.16 247.093 1161.39 247.489 1162.66 247.806 1163.94L247.841 1164.01z" id="Shape" fill="#0d0c22" stroke="none"/><path d="M472.623 590.836c-45.941 19.667-98.077 41.966-165.647 41.966C278.71 632.746 250.58 628.868 223.353 621.274l46.733 479.806C271.74 1121.13 280.876 1139.83 295.679 1153.46 310.482 1167.09 329.87 1174.65 349.992 1174.65 349.992 1174.65 416.254 1178.09 438.365 1178.09 462.161 1178.09 533.516 1174.65 533.516 1174.65c20.12.0 39.503-7.57000000000016 54.303-21.2C602.619 1139.82 611.752 1121.13 613.406 1101.08l50.053-530.204C641.091 563.237 618.516 558.161 593.068 558.161 549.054 558.144 513.591 573.303 472.623 590.836z" id="Shape" fill="#fff" stroke="none"/><path d="M78.6885 386.132 79.4799 386.872 79.9962 387.182C79.5987 386.787 79.1603 386.435 78.6885 386.132z" id="Shape" fill="#0d0c22" stroke="none"/><path d="M879.567 341.849 872.53 306.352C866.215 274.503 851.882 244.409 819.19 232.898 808.711 229.215 796.821 227.633 788.786 220.01 780.751 212.388 778.376 200.55 776.518 189.572 773.076 169.423 769.842 149.257 766.314 129.143 763.269 111.85 760.86 92.4243 752.928 76.56c-10.324-21.3016-31.746-33.7591-53.048-42.001C688.965 30.4844 677.826 27.0375 666.517 24.2352 613.297 10.1947 557.342 5.03277 502.591 2.09047 436.875-1.53577 370.983-.443233 305.422 5.35968 256.625 9.79894 205.229 15.1674 158.858 32.0469c-16.948 6.1771-34.413 13.593-47.3 26.6872C95.7448 74.8221 90.5829 99.7026 102.128 119.765c8.208 14.247 22.111 24.313 36.857 30.972C158.192 159.317 178.251 165.846 198.829 170.215c57.297 12.664 116.642 17.636 175.178 19.753C438.887 192.586 503.87 190.464 568.44 183.618 584.408 181.863 600.347 179.758 616.257 177.304 634.995 174.43 647.022 149.928 641.499 132.859 634.891 112.453 617.134 104.538 597.055 107.618 594.095 108.082 591.153 108.512 588.193 108.942L586.06 109.252C579.257 110.113 572.455 110.915 565.653 111.661c-14.052 1.514-28.138 2.753-42.259 3.717C491.768 117.58 460.057 118.595 428.363 118.647c-31.144.0-62.305-.878-93.38-2.92500000000001C320.805 114.793 306.661 113.611 292.552 112.177 286.134 111.506 279.733 110.801 273.333 110.009L267.241 109.235 265.917 109.046 259.602 108.134C246.697 106.189 233.792 103.953 221.025 101.251 219.737 100.965 218.584 100.249 217.758 99.2193 216.932 98.1901 216.482 96.9099 216.482 95.5903 216.482 94.2706 216.932 92.9904 217.758 91.9612 218.584 90.9319 219.737 90.2152 221.025 89.9293H221.266C232.33 87.5721 243.479 85.5589 254.663 83.8038 258.392 83.2188 262.131 82.6453 265.882 82.0832H265.985C272.988 81.6186 280.026 80.3625 286.994 79.5366 347.624 73.2302 408.614 71.0801 469.538 73.1014 499.115 73.9618 528.676 75.6996 558.116 78.6935 564.448 79.3474 570.746 80.0357 577.043 80.8099 579.452 81.1025 581.878 81.4465 584.305 81.7391L589.191 82.4445C603.438 84.5667 617.61 87.1419 631.708 90.1703 652.597 94.7128 679.422 96.1925 688.713 119.077 691.673 126.338 693.015 134.408 694.649 142.03L696.731 151.752C696.786 151.926 696.826 152.105 696.852 152.285 701.773 175.227 706.7 198.169 711.632 221.111 711.994 222.806 712.002 224.557 711.657 226.255 711.312 227.954 710.621 229.562 709.626 230.982 708.632 232.401 707.355 233.6 705.877 234.504 704.398 235.408 702.75 235.997 701.033 236.236H700.895L697.884 236.649 694.908 237.044C685.478 238.272 676.038 239.419 666.586 240.486 647.968 242.608 629.322 244.443 610.648 245.992 573.539 249.077 536.356 251.102 499.098 252.066 480.114 252.57 461.135 252.806 442.162 252.771 366.643 252.712 291.189 248.322 216.173 239.625 208.051 238.662 199.93 237.629 191.808 236.58 198.106 237.389 187.231 235.96 185.029 235.651 179.867 234.928 174.705 234.177 169.543 233.397 152.216 230.798 134.993 227.598 117.7 224.793 96.7944 221.352 76.8005 223.073 57.8906 233.397c-15.5221 8.494-28.0851 21.519-36.013 37.338-8.1559 16.862-10.582 35.221-14.22974 53.34-3.64777 18.118-9.32591 37.613-7.17511 56.213C5.10128 420.431 33.165 453.054 73.5313 460.35 111.506 467.232 149.687 472.807 187.971 477.556 338.361 495.975 490.294 498.178 641.155 484.129 653.44 482.982 665.708 481.732 677.959 480.378 681.786 479.958 685.658 480.398 689.292 481.668S696.23 485.005 698.962 487.717 703.784 493.718 705.08 497.342C706.377 500.967 706.846 504.836 706.453 508.665L702.633 545.797c-7.697 75.031-15.394 150.057-23.091 225.077-8.029 78.783-16.111 157.56-24.244 236.326C653.004 1029.39 650.71 1051.57 648.416 1073.74 646.213 1095.58 645.904 1118.1 641.757 1139.68 635.218 1173.61 612.248 1194.45 578.73 1202.07 548.022 1209.06 516.652 1212.73 485.161 1213.01 450.249 1213.2 415.355 1211.65 380.443 1211.84 343.173 1212.05 297.525 1208.61 268.756 1180.87 243.479 1156.51 239.986 1118.36 236.545 1085.37 231.957 1041.7 227.409 998.039 222.9 954.381L197.607 711.615 181.244 554.538C180.968 551.94 180.693 549.376 180.435 546.76 178.473 528.023 165.207 509.681 144.301 510.627 126.407 511.418 106.069 526.629 108.168 546.76l12.13 116.454 25.087 240.89C152.532 972.528 159.661 1040.96 166.773 1109.41 168.15 1122.52 169.44 1135.67 170.885 1148.78 178.749 1220.43 233.465 1259.04 301.224 1269.91 340.799 1276.28 381.337 1277.59 421.497 1278.24 472.979 1279.07 524.977 1281.05 575.615 1271.72 650.653 1257.95 706.952 1207.85 714.987 1130.13 717.282 1107.69 719.576 1085.25 721.87 1062.8 729.498 988.559 737.115 914.313 744.72 840.061l24.881-242.61 11.408-111.188C781.577 480.749 783.905 475.565 787.649 471.478 791.392 467.391 796.352 464.617 801.794 463.567 823.25 459.386 843.761 452.245 859.023 435.916c24.295-25.998 29.13-59.895 20.544-94.067zM72.7365 365.835C73.247 365.68 72.3065 368.484 71.9034 369.792 71.8229 367.813 71.984 366.058 72.7365 365.835zm1.7756 16.105C74.6842 381.819 75.2003 382.508 75.7337 383.334 74.925 382.576 74.4089 382.009 74.4949 381.94H74.5121zM76.5597 384.641C77.6004 385.897 78.1569 386.689 76.5597 384.641zM80.7002 387.979h.2727C80.9729 388.313 81.473 388.645 81.6548 388.979 81.3533 388.612 81.0186 388.277 80.6548 387.979H80.7002zM800.796 382.989C793.088 390.319 781.473 393.726 769.996 395.43c-128.704 19.099-259.283 28.769-389.399 24.502C287.476 416.749 195.336 406.407 103.144 393.382 94.1102 392.109 84.3197 390.457 78.1082 383.798c-11.7004-12.561-5.9534-37.854-2.9079-53.03C77.9878 316.865 83.3218 298.334 99.8572 296.355 125.667 293.327 155.64 304.218 181.175 308.09 211.917 312.781 242.774 316.538 273.745 319.36 405.925 331.405 540.325 329.529 671.92 311.91 695.905 308.686 719.805 304.941 743.619 300.674 764.835 296.871 788.356 289.731 801.175 311.703 809.967 326.673 811.137 346.701 809.778 363.615 809.359 370.984 806.139 377.915 800.779 382.989H800.796z" id="Shape" fill="#fff" fill-rule="evenodd" stroke="none"/></g></g></svg></a></li></ol><ol class=menu id=main-menu><li><a href=/><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-home" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><polyline points="5 12 3 12 12 3 21 12 19 12"/><path d="M5 12v7a2 2 0 002 2h10a2 2 0 002-2v-7"/><path d="M9 21v-6a2 2 0 012-2h2a2 2 0 012 2v6"/></svg><span>Home</span></a></li><li><a href=/about-me/><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-user" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><circle cx="12" cy="7" r="4"/><path d="M6 21v-2a4 4 0 014-4h4a4 4 0 014 4v2"/></svg><span>About Me</span></a></li><div class=menu-bottom-section><li id=dark-mode-toggle><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-toggle-left" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><circle cx="8" cy="12" r="2"/><rect x="2" y="6" width="20" height="12" rx="6"/></svg><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-toggle-right" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><circle cx="16" cy="12" r="2"/><rect x="2" y="6" width="20" height="12" rx="6"/></svg><span>Dark Mode</span></li></div></ol></aside><main class="main full-width"><article class=main-article><header class=article-header><div class=article-details><div class=article-title-wrapper><h2 class=article-title><a href=/posts/2016-09-09-cjeu-rules-that-pay-for-delay/>CJEU rules that pay-for-delay agreements likely violate competition law where reverse payments occur without justifiable explanation</a></h2></div><footer class=article-time><div><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-calendar-time" width="56" height="56" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><path d="M11.795 21H5a2 2 0 01-2-2V7a2 2 0 012-2h12a2 2 0 012 2v4"/><circle cx="18" cy="18" r="4"/><path d="M15 3v4"/><path d="M7 3v4"/><path d="M3 11h16"/><path d="M18 16.496V18l1 1"/></svg><time class=article-time--published>Jan 30, 2020</time></div><div><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-clock" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><circle cx="12" cy="12" r="9"/><polyline points="12 7 12 12 15 15"/></svg><time class=article-time--reading>7 minute read</time></div></footer></div></header><section class=article-content><p>In today’s decision in <em>Generics (UK) v. Competition and Markets Authority</em> [C-307/18, <a class=link href="http://curia.europa.eu/juris/document/document.jsf?text=&docid=222887&pageIndex=0&doclang=EN&mode=req&dir=&occ=first&part=1&cid=3571569" target=_blank rel=noopener><strong>here</strong></a>], the Court of Justice of the European Union (CJEU) ruled that pay-for-delay agreements may violate Articles 101 and 102 of the Treaty on the Functioning of the European Union (TFEU). Under a pay-for-delay agreement, the holder of a pharmaceutical patent pays generics to stay off the market or delay their entry on the market. <strong>The decision is significant because it is the first time the CJEU addresses this issue.</strong><br>The judgment follows very closey the Opinion of Advocate-General (AG) Kokott, which was only handed down last week [<a class=link href="http://curia.europa.eu/juris/document/document.jsf?text=&docid=222521&pageIndex=0&doclang=EN&mode=req&dir=&occ=first&part=1&cid=3401797" target=_blank rel=noopener><strong>here</strong></a>]. [Says Merpel: perhaps the Court is clearing its docket of important UK referrals before some Brits “<a class=link href=https://www.gov.uk/government/news/brexit-coin-light-display-and-ready-to-trade-campaign-among-plans-to-mark-31-january-reveals-pm target=_blank rel=noopener>celebrate</a>” Brexit Day tomorrow…]</p><p><strong>Case background</strong><br>The case concerns an antidepressant medicine, paroxetine, developed by GlaxoSmithKline (GSK) and protected under various patents. Between 2001 and 2003, GSK entered into agreements with three generics companies. In short, the agreements: (i) put in place distribution arrangements whereby the generics companies would resell GSK-produced paroxetine; (ii) provided for various payments of GSK to the generics companies; and (iii) precluded the generics companies from making, importing or supplying paroxetine in the UK.</p><p>In December 2003, another generics company obtained a marketing authorization (MA) for paroxetine in the UK and successfully defended itself against a patent infringement suit brought by GSK. Consequently, the three generics companies terminated their agreements with GSK. The independent market entry of these generics companies had a significant impact on prices: by December 2005, average prices of paroxetine had fallen by around 74%.</p><p><strong>Comment by Katfriend Gaëlle Béquet</strong></p><p>Any mention of pay-for-delay makes this Kat think of his old friend <a class=link href=https://www.brinkhof.com/en/people/gaelle-bequet/ target=_blank rel=noopener><strong>Gaëlle Béquet</strong></a>, with whom he spent many cheerful evenings when they were both young associates before the Amsterdam patent bar. Gaëlle specializes in competition law and has kindly agreed to share some thoughts on today’s decision by the CJEU.</p><p><a class=link href=https://1.bp.blogspot.com/-IGITUiCKCko/XjNYg5ozIKI/AAAAAAAAAGM/fCNoA0nGrjkBfD5tydQbXrC69ZGv2YAwwCLcBGAsYHQ/s1600/Screen%2BShot%2B2020-01-30%2Bat%2B23.25.55.png target=_blank rel=noopener><img src=https://1.bp.blogspot.com/-IGITUiCKCko/XjNYg5ozIKI/AAAAAAAAAGM/fCNoA0nGrjkBfD5tydQbXrC69ZGv2YAwwCLcBGAsYHQ/s320/Screen%2BShot%2B2020-01-30%2Bat%2B23.25.55.png loading=lazy></a></p><p>Play around, but don&rsquo;t kill the competition _(Meme Credit: Makeameme.org)<br>_</p><p><strong>Over to Gaëlle:</strong></p><p>The scenario of Generics (UK)is familiar to that in <a class=link href="http://curia.europa.eu/juris/document/document.jsf?text=&docid=208862&pageIndex=0&doclang=FR&mode=lst&dir=&occ=first&part=1&cid=2195832" target=_blank rel=noopener><strong><em>Servier</em></strong></a> and <a class=link href="http://curia.europa.eu/juris/liste.jsf?num=T-472/13&language=en" target=_blank rel=noopener><strong><em>Lundbeck</em></strong></a>, heard by the General Court (GC) and <a class=link href=https://ec.europa.eu/competition/antitrust/cases/dec_docs/39685/39685_1976_7.pdf target=_blank rel=noopener><strong><em>Johnson&Johnson</em></strong></a> a European Commission decision: an originator trying to protect its market position for a blockbuster from generic entry. The CJEU followed the line previously set by the European Commission, the GC and the AG. The decision therefore comes as no surprise for readers following developments in this area.</p><p><strong>Originator and generic are potential competitors</strong></p><p>The CJEU reiterated that the prohibition to restrict competition pursuant to article 101 TFEU with respect to horizontal cooperation only applies to competitors or potential competitors (§32). Whether a generic, which is not yet on the market, must be considered as potential competition for an originator, depends on its real and concrete possibilities to enter the market, absent the settlement agreements (§37).</p><p>Such possibilities require that the generic has taken the necessary preparatory steps to enter the market (e.g. MA, stock of generics,patent litigation), and that there are no insurmountable barriers to entry (§44-45). In line with the AG’s Opinion, the CJEU considered that patents are no such insurmountable barrier because of the uncertainty around the validity of patents and the possibility for a generic to launch-at-risk (§46-51). Unsurprisingly given the overall approach, the CJEU also held that the fact that an interim injunction had been granted does not preclude potential competition (§53).</p><p>Taken at face value, there are quite a number of commonly recognized entry barriers present in this case: the medicines sector is characterized by strong entry barriers and is strictly regulated. Also, a launch “at risk” of a generic competing against a blockbuster could lead to a huge exposure of the generic if the patent turns out to be valid and infringed. It follows from established case law that regulatory barriers, access to infrastructures and IP rights can create a so-called “blocking position” on the market (**<a class=link href="https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52014XC0328%2801%29&from=EN" target=_blank rel=noopener>Guidelines Technology Transfer</a> **§32-33).</p><p>Nevertheless, the CJEU ruled that a competitive relationship was present in this case. The reason for the decision is relatively intuitive: if market players feel the need to conclude an agreement to keep one of them out of a specific market, this is a strong indication that a competitive relationship exists between them (§55). <strong>In other words, in a pay-for-delay case, the competition law assessment of the agreements almost precedes the question whether the parties to the agreement are competitors.</strong> The CJEU (and before it the GC and AG) seemed to be reasoning to the goal that it wished to achieve.</p><p>The CJEU’s considerations around potential competition show that patent-related matters remain a source of constant struggles for competition law. On the one hand, patents are presumed to be valid, creating entry barriers; on the other hand, there is a constant uncertainty regarding the outcome of validity proceedings, which limits the relevance of patent validity as a factor when applying competition law. The economic and legal context around patents makes it difficult to establish whether they are capable of restricting competition that would otherwise have existed – a phenomenon known from cases involving Standard Essential Patents (SEPs).</p><p><strong>Agreements that have the object or effect to restrict competition</strong></p><p>Also in line with the AG, the CJEU considered that pay-for-delay agreements may have the object to restrict competition (as opposed to agreements having the effect of restricting competition). Qualifying an agreement of restriction by objectreleases a competition authority of the obligation to prove that competition is in fact distorted by the agreement. Hence, the agreement is considered to be harmful to competition by its very nature.</p><p>Although the AG condemned the present agreements, the CJEU nuanced the nature of the agreements, stating that they cannot be regarded as agreements bringing to an end entirely fictitious disputes, or designed with the sole aim of disguising a market-sharing or market-exclusion agreement (§76).</p><p>The fact that a settlement involves transfers of value (pecuniary or non-pecuniary) by the originator to the generic (a so-called reverse payment) is not sufficient ground to classify it as a “restriction by object”, since those transfers of value may prove to be justified, e.g. to compensate the litigation costs (§85-86). <strong>This reverse payment, however, is to be qualified as a restriction by object when it cannot have any explanation other than the commercial interest of both originator and generic (§87).</strong></p><p>If the agreement has pro-competitive effects for consumers, those may be taken into account, provided that those are sufficiently significant, so that they justify a reasonable doubt as to whether the settlement agreement harmed competition (§107). A slight reduction in the price of the medicine is in any case no such pro-competitive effect (§109).</p><p>A settlement that may not be qualified as a restriction by object may still be a restriction by effect and, therefore, prohibited. This however requires a more thorough analysis of the effects of the agreement for the competition. The CJEU mentioned that the likelihood of success in the validity proceedings, i.e. the validity of the patent in general, is not relevant for this assessment (§121).</p><p><strong>Abuse of dominance</strong></p><p>After Servier, this is the second EU case where abuse of dominance by the originator was established by the relevant competition authority, next to infringement of the cartel prohibition. In Servier, the GC annulled the Commission decision with respect to the finding of abuse of dominance because the Commission had failed to establish the existence of a dominant position. To that end, the Commission in its assessment of dominance had not sufficiently considered the competitive pressure exerted by other molecules for the treatment of the same disease. The UK Competition Authority seems to have taken this competitive pressure into account and now requests guidance on the concept of the abuse itself.</p><p>The CJEU unsurprisingly considered that a dominant undertaking, entering an agreement restricting article 101 TFEU, may at the same time abuse its dominant position. <strong>The cumulative effects that restrict competition arising from the conclusion of the various agreements with the different generics may be considered to have a foreclosure effect on the market, ultimately harming consumers.</strong></p><p><strong>Take-away message</strong></p><p>The take-away message from this decision may be summarized as follows:</p><ul><li><p>If a generic has taken any preparatory steps to enter the market, it is likely to be considered a potential competitor of the originator. Roughly said, the existence of a horizontal (settlement) agreement between originator and generic already shows potential competition.</p></li><li><p>If there is a reverse payment from originator to generic, that has no explanation other than the commercial interest of both parties, it is very likely to be anticompetitive, also when there are certain pro-competitive effects. </p></li></ul><p><strong>For interested readers, the GC&rsquo;s <em>Servier</em> and <em>Lundbeck</em> decisions provide additional interesting insights on this topic in relation to what should be considered as a value transfer and when licensing and distribution agreements may be considered anticompetitive.</strong> For Kats and readers proficient in Dutch, my case notes on the Serviercase can be found hereand <a class=link href=https://www.brinkhof.com/app/uploads/2019/07/Brinkhof_Noot_MM_Servier-RO.pdf target=_blank rel=noopener>here</a>.</p></section><footer class=article-footer><section class=article-copyright><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-copyright" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><circle cx="12" cy="12" r="9"/><path d="M14.5 9a3.5 4 0 100 6"/></svg><span>Licensed under CC BY-NC-SA 4.0</span></section></footer></article><footer class=site-footer><section class=copyright>&copy;
2020 -
2022 ZYChimne</section><section class=powerby>Built with <a href=https://gohugo.io/ target=_blank rel=noopener>Hugo</a><br>Theme <b><a href=https://github.com/CaiJimmy/hugo-theme-stack target=_blank rel=noopener data-version=3.11.0>Stack</a></b> designed by <a href=https://jimmycai.com target=_blank rel=noopener>Jimmy</a></section></footer><div class=pswp tabindex=-1 role=dialog aria-hidden=true><div class=pswp__bg></div><div class=pswp__scroll-wrap><div class=pswp__container><div class=pswp__item></div><div class=pswp__item></div><div class=pswp__item></div></div><div class="pswp__ui pswp__ui--hidden"><div class=pswp__top-bar><div class=pswp__counter></div><button class="pswp__button pswp__button--close" title="Close (Esc)"></button>
<button class="pswp__button pswp__button--share" title=Share></button>
<button class="pswp__button pswp__button--fs" title="Toggle fullscreen"></button>
<button class="pswp__button pswp__button--zoom" title="Zoom in/out"></button><div class=pswp__preloader><div class=pswp__preloader__icn><div class=pswp__preloader__cut><div class=pswp__preloader__donut></div></div></div></div></div><div class="pswp__share-modal pswp__share-modal--hidden pswp__single-tap"><div class=pswp__share-tooltip></div></div><button class="pswp__button pswp__button--arrow--left" title="Previous (arrow left)"></button>
<button class="pswp__button pswp__button--arrow--right" title="Next (arrow right)"></button><div class=pswp__caption><div class=pswp__caption__center></div></div></div></div></div><script src=https://cdn.jsdelivr.net/npm/photoswipe@4.1.3/dist/photoswipe.min.js integrity="sha256-ePwmChbbvXbsO02lbM3HoHbSHTHFAeChekF1xKJdleo=" crossorigin=anonymous defer></script><script src=https://cdn.jsdelivr.net/npm/photoswipe@4.1.3/dist/photoswipe-ui-default.min.js integrity="sha256-UKkzOn/w1mBxRmLLGrSeyB4e1xbrp4xylgAWb3M42pU=" crossorigin=anonymous defer></script><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/photoswipe@4.1.3/dist/default-skin/default-skin.css integrity="sha256-c0uckgykQ9v5k+IqViZOZKc47Jn7KQil4/MP3ySA3F8=" crossorigin=anonymous><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/photoswipe@4.1.3/dist/photoswipe.css integrity="sha256-SBLU4vv6CA6lHsZ1XyTdhyjJxCjPif/TRkjnsyGAGnE=" crossorigin=anonymous></main></div><script src=https://cdn.jsdelivr.net/npm/node-vibrant@3.1.5/dist/vibrant.min.js integrity="sha256-5NovOZc4iwiAWTYIFiIM7DxKUXKWvpVEuMEPLzcm5/g=" crossorigin=anonymous></script><script type=text/javascript src=/ts/main.js defer></script>
<script>(function(){const e=document.createElement("link");e.href="https://fonts.googleapis.com/css2?family=Lato:wght@300;400;700&display=swap",e.type="text/css",e.rel="stylesheet",document.head.appendChild(e)})()</script></body></html>